deltatrials
Completed OBSERVATIONAL NCT03451734

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Sponsor: Air Force Military Medical University, China

Conditions Metabolic Syndrome Schizophrenia
Interventions adjunctive group antipsychotic medications metformin and lifestyle intervention
Updated 15 times since 2018 Last updated: Aug 10, 2021 Started: Jan 23, 2018 Primary completion: Jun 30, 2021 Completion: Jun 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Metabolic Syndrome and Schizophrenia and is currently completed. Air Force Military Medical University, China leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jul 2020 · 19 months · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Apr 2023 · 16 months · monthly snapshot~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Apr 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2021 — Apr 2023 [monthly]

    Completed

  5. Sep 2021 — Dec 2021 [monthly]

    Completed

    Status: Recruiting → Completed

▶ Show 10 earlier versions

  1. Feb 2021 — Sep 2021 [monthly]

    Recruiting

  2. Jan 2021 — Feb 2021 [monthly]

    Recruiting

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  4. Sep 2020 — Nov 2020 [monthly]

    Recruiting

  5. Jul 2020 — Sep 2020 [monthly]

    Recruiting

  6. Dec 2018 — Jul 2020 [monthly]

    Recruiting

  7. Jun 2018 — Dec 2018 [monthly]

    Recruiting

  8. May 2018 — Jun 2018 [monthly]

    Recruiting

  9. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  10. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Air Force Military Medical University, China
  • Capital Medical University
  • Central South University
  • China Medical University, China
  • First Affiliated Hospital Xi'an Jiaotong University
  • First Affiliated Hospital of Chongqing Medical University
  • First Affiliated Hospital of Harbin Medical University
  • First Affiliated Hospital of Kunming Medical University
  • First Affiliated Hospital of Zhejiang University
  • Guangzhou Mental Hospital
  • Hebei Medical University
  • Jiangsu Province Nanjing Brain Hospital
  • Shanghai Jiao Tong University School of Medicine
  • Shanghai Mental Health Center
  • Shanxi Medical University
  • Shenzhen Mental Health Center
  • Sun Yat-sen University
  • The First Affiliated Hospital of Zhengzhou University
  • West China Hospital
  • Wuhan Mental Health Centre
  • Xiangya Hospital of Central South University
Data source: Central South University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations